1. Home
  2. ENLV vs FCUV Comparison

ENLV vs FCUV Comparison

Compare ENLV & FCUV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Enlivex Therapeutics Ltd.

ENLV

Enlivex Therapeutics Ltd.

HOLD

Current Price

$0.83

Market Cap

26.6M

Sector

Health Care

ML Signal

HOLD

Logo Focus Universal Inc.

FCUV

Focus Universal Inc.

HOLD

Current Price

$1.58

Market Cap

25.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
ENLV
FCUV
Founded
2005
2012
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
26.6M
25.3M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
ENLV
FCUV
Price
$0.83
$1.58
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$7.00
N/A
AVG Volume (30 Days)
11.7M
19.2K
Earning Date
11-28-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$387,457.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.79
$1.72
52 Week High
$2.10
$10.90

Technical Indicators

Market Signals
Indicator
ENLV
FCUV
Relative Strength Index (RSI) 36.38 22.44
Support Level $0.80 $3.41
Resistance Level $0.88 $3.67
Average True Range (ATR) 0.09 0.35
MACD -0.02 -0.21
Stochastic Oscillator 6.69 0.82

Price Performance

Historical Comparison
ENLV
FCUV

About ENLV Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

Share on Social Networks: